BioMarin Pharmaceutical, Inc. (BMRN)
65.68
+0.17
(+0.26%)
USD |
NASDAQ |
Sep 11, 16:00
65.72
+0.04
(+0.06%)
Pre-Market: 20:00
BioMarin Pharmaceutical Market Cap : 12.71B for Sept. 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 11, 2026 | 12.71B |
| September 10, 2026 | 12.68B |
| September 09, 2026 | 12.47B |
| September 08, 2026 | 12.51B |
| September 04, 2026 | 12.88B |
| September 03, 2026 | 12.86B |
| September 02, 2026 | 12.96B |
| September 01, 2026 | 12.55B |
| August 31, 2026 | 12.62B |
| August 28, 2026 | 12.51B |
| August 27, 2026 | 12.64B |
| August 26, 2026 | 12.70B |
| August 25, 2026 | 12.80B |
| August 24, 2026 | 12.59B |
| August 21, 2026 | 12.91B |
| August 20, 2026 | 13.10B |
| August 19, 2026 | 13.42B |
| August 18, 2026 | 12.96B |
| August 17, 2026 | 12.90B |
| August 14, 2026 | 13.04B |
| August 13, 2026 | 13.26B |
| August 12, 2026 | 13.59B |
| August 11, 2026 | 13.46B |
| August 10, 2026 | 13.33B |
| August 07, 2026 | 12.35B |
| Date | Value |
|---|---|
| August 06, 2026 | 11.89B |
| August 05, 2026 | 11.59B |
| August 04, 2026 | 11.75B |
| August 03, 2026 | 11.60B |
| July 31, 2026 | 11.60B |
| July 30, 2026 | 11.71B |
| July 29, 2026 | 11.86B |
| July 28, 2026 | 12.00B |
| July 27, 2026 | 11.65B |
| July 24, 2026 | 11.47B |
| July 23, 2026 | 11.38B |
| July 22, 2026 | 11.29B |
| July 21, 2026 | 11.44B |
| July 20, 2026 | 11.42B |
| July 17, 2026 | 11.52B |
| July 16, 2026 | 11.60B |
| July 15, 2026 | 11.39B |
| July 14, 2026 | 11.33B |
| July 13, 2026 | 11.44B |
| July 10, 2026 | 11.43B |
| July 09, 2026 | 11.59B |
| July 08, 2026 | 11.55B |
| July 07, 2026 | 11.66B |
| July 06, 2026 | 11.36B |
| July 02, 2026 | 11.40B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Alnylam Pharmaceuticals, Inc. | 33.26B |
| Vertex Pharmaceuticals, Inc. | 130.59B |
| BridgeBio Pharma, Inc. | 14.15B |
| Incyte Corp. | 24.41B |
| Ionis Pharmaceuticals, Inc. | 8.979B |
Market Cap Related Metrics
| PE Ratio | 177.08 |
| PS Ratio | 3.688 |
| Price to Book Value | 2.011 |
| Price to Free Cash Flow | 17.58 |
| Price | 65.68 |
| Earnings Yield | 0.56% |
| Operating PE Ratio | 19.93 |
| Normalized PE Ratio | 33.34 |